 | • レポートコード：MRC2-11QY01519 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はがんの温熱治療のグローバル市場について調査・分析したレポートです。種類別（マイクロ波ハイパーサーミア装置、超音波ハイパーサーミア装置、赤外線治療装置、短波治療装置）市場規模、用途別（病院、診療所、研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別がんの温熱治療の競争状況、市場シェア ・世界のがんの温熱治療市場：種類別市場規模 2015年-2020年（マイクロ波ハイパーサーミア装置、超音波ハイパーサーミア装置、赤外線治療装置、短波治療装置） ・世界のがんの温熱治療市場：種類別市場規模予測 2021年-2026年（マイクロ波ハイパーサーミア装置、超音波ハイパーサーミア装置、赤外線治療装置、短波治療装置） ・世界のがんの温熱治療市場：用途別市場規模 2015年-2020年（病院、診療所、研究所） ・世界のがんの温熱治療市場：用途別市場規模予測 2021年-2026年（病院、診療所、研究所） ・北米のがんの温熱治療市場分析：米国、カナダ ・ヨーロッパのがんの温熱治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのがんの温熱治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のがんの温熱治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのがんの温熱治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Andromedic Sri、Celsius42 GmbH、Huahang、Pyrexar Medical、Perseon Medical、Omron Corporation、Sjn AG Yamamoto Vinita ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Hyperthermia Treatment for Cancer Market
The global Hyperthermia Treatment for Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Hyperthermia Treatment for Cancer Scope and Market Size
Hyperthermia Treatment for Cancer market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hyperthermia Treatment for Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Hyperthermia Treatment for Cancer market is segmented into
Microwave Hyperthermia Device
Ultrasound Hyperthermia Device
Infrared Therapy Device
Short-wave Therapy Device
Segment by Application, the Hyperthermia Treatment for Cancer market is segmented into
Hospitals
Clinics
Research Institutes
Regional and Country-level Analysis
The Hyperthermia Treatment for Cancer market is analysed and market size information is provided by regions (countries).
The key regions covered in the Hyperthermia Treatment for Cancer market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Hyperthermia Treatment for Cancer Market Share Analysis
Hyperthermia Treatment for Cancer market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Hyperthermia Treatment for Cancer business, the date to enter into the Hyperthermia Treatment for Cancer market, Hyperthermia Treatment for Cancer product introduction, recent developments, etc.
The major vendors covered:
Andromedic Sri
Celsius42 GmbH
Huahang
Pyrexar Medical
Perseon Medical
Omron Corporation
Sjn AG Yamamoto Vinita
…
1 Study Coverage
1.1 Hyperthermia Treatment for Cancer Product Introduction
1.2 Market Segments
1.3 Key Hyperthermia Treatment for Cancer Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Hyperthermia Treatment for Cancer Market Size Growth Rate by Type
1.4.2 Microwave Hyperthermia Device
1.4.3 Ultrasound Hyperthermia Device
1.4.4 Infrared Therapy Device
1.4.5 Short-wave Therapy Device
1.5 Market by Application
1.5.1 Global Hyperthermia Treatment for Cancer Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Research Institutes
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Hyperthermia Treatment for Cancer Market Size, Estimates and Forecasts
2.1.1 Global Hyperthermia Treatment for Cancer Revenue 2015-2026
2.1.2 Global Hyperthermia Treatment for Cancer Sales 2015-2026
2.2 Global Hyperthermia Treatment for Cancer, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Hyperthermia Treatment for Cancer Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Hyperthermia Treatment for Cancer Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Hyperthermia Treatment for Cancer Competitor Landscape by Players
3.1 Hyperthermia Treatment for Cancer Sales by Manufacturers
3.1.1 Hyperthermia Treatment for Cancer Sales by Manufacturers (2015-2020)
3.1.2 Hyperthermia Treatment for Cancer Sales Market Share by Manufacturers (2015-2020)
3.2 Hyperthermia Treatment for Cancer Revenue by Manufacturers
3.2.1 Hyperthermia Treatment for Cancer Revenue by Manufacturers (2015-2020)
3.2.2 Hyperthermia Treatment for Cancer Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Hyperthermia Treatment for Cancer Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Hyperthermia Treatment for Cancer Revenue in 2019
3.2.5 Global Hyperthermia Treatment for Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Hyperthermia Treatment for Cancer Price by Manufacturers
3.4 Hyperthermia Treatment for Cancer Manufacturing Base Distribution, Product Types
3.4.1 Hyperthermia Treatment for Cancer Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hyperthermia Treatment for Cancer Product Type
3.4.3 Date of International Manufacturers Enter into Hyperthermia Treatment for Cancer Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Hyperthermia Treatment for Cancer Market Size by Type (2015-2020)
4.1.1 Global Hyperthermia Treatment for Cancer Sales by Type (2015-2020)
4.1.2 Global Hyperthermia Treatment for Cancer Revenue by Type (2015-2020)
4.1.3 Hyperthermia Treatment for Cancer Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Hyperthermia Treatment for Cancer Market Size Forecast by Type (2021-2026)
4.2.1 Global Hyperthermia Treatment for Cancer Sales Forecast by Type (2021-2026)
4.2.2 Global Hyperthermia Treatment for Cancer Revenue Forecast by Type (2021-2026)
4.2.3 Hyperthermia Treatment for Cancer Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Hyperthermia Treatment for Cancer Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Hyperthermia Treatment for Cancer Market Size by Application (2015-2020)
5.1.1 Global Hyperthermia Treatment for Cancer Sales by Application (2015-2020)
5.1.2 Global Hyperthermia Treatment for Cancer Revenue by Application (2015-2020)
5.1.3 Hyperthermia Treatment for Cancer Price by Application (2015-2020)
5.2 Hyperthermia Treatment for Cancer Market Size Forecast by Application (2021-2026)
5.2.1 Global Hyperthermia Treatment for Cancer Sales Forecast by Application (2021-2026)
5.2.2 Global Hyperthermia Treatment for Cancer Revenue Forecast by Application (2021-2026)
5.2.3 Global Hyperthermia Treatment for Cancer Price Forecast by Application (2021-2026)
6 North America
6.1 North America Hyperthermia Treatment for Cancer by Country
6.1.1 North America Hyperthermia Treatment for Cancer Sales by Country
6.1.2 North America Hyperthermia Treatment for Cancer Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Hyperthermia Treatment for Cancer Market Facts & Figures by Type
6.3 North America Hyperthermia Treatment for Cancer Market Facts & Figures by Application
7 Europe
7.1 Europe Hyperthermia Treatment for Cancer by Country
7.1.1 Europe Hyperthermia Treatment for Cancer Sales by Country
7.1.2 Europe Hyperthermia Treatment for Cancer Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Hyperthermia Treatment for Cancer Market Facts & Figures by Type
7.3 Europe Hyperthermia Treatment for Cancer Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Hyperthermia Treatment for Cancer by Region
8.1.1 Asia Pacific Hyperthermia Treatment for Cancer Sales by Region
8.1.2 Asia Pacific Hyperthermia Treatment for Cancer Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Hyperthermia Treatment for Cancer Market Facts & Figures by Type
8.3 Asia Pacific Hyperthermia Treatment for Cancer Market Facts & Figures by Application
9 Latin America
9.1 Latin America Hyperthermia Treatment for Cancer by Country
9.1.1 Latin America Hyperthermia Treatment for Cancer Sales by Country
9.1.2 Latin America Hyperthermia Treatment for Cancer Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Hyperthermia Treatment for Cancer Market Facts & Figures by Type
9.3 Central & South America Hyperthermia Treatment for Cancer Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Hyperthermia Treatment for Cancer by Country
10.1.1 Middle East and Africa Hyperthermia Treatment for Cancer Sales by Country
10.1.2 Middle East and Africa Hyperthermia Treatment for Cancer Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Hyperthermia Treatment for Cancer Market Facts & Figures by Type
10.3 Middle East and Africa Hyperthermia Treatment for Cancer Market Facts & Figures by Application
11 Company Profiles
11.1 Andromedic Sri
11.1.1 Andromedic Sri Corporation Information
11.1.2 Andromedic Sri Description and Business Overview
11.1.3 Andromedic Sri Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Andromedic Sri Hyperthermia Treatment for Cancer Products Offered
11.1.5 Andromedic Sri Related Developments
11.2 Celsius42 GmbH
11.2.1 Celsius42 GmbH Corporation Information
11.2.2 Celsius42 GmbH Description and Business Overview
11.2.3 Celsius42 GmbH Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Celsius42 GmbH Hyperthermia Treatment for Cancer Products Offered
11.2.5 Celsius42 GmbH Related Developments
11.3 Huahang
11.3.1 Huahang Corporation Information
11.3.2 Huahang Description and Business Overview
11.3.3 Huahang Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Huahang Hyperthermia Treatment for Cancer Products Offered
11.3.5 Huahang Related Developments
11.4 Pyrexar Medical
11.4.1 Pyrexar Medical Corporation Information
11.4.2 Pyrexar Medical Description and Business Overview
11.4.3 Pyrexar Medical Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Pyrexar Medical Hyperthermia Treatment for Cancer Products Offered
11.4.5 Pyrexar Medical Related Developments
11.5 Perseon Medical
11.5.1 Perseon Medical Corporation Information
11.5.2 Perseon Medical Description and Business Overview
11.5.3 Perseon Medical Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Perseon Medical Hyperthermia Treatment for Cancer Products Offered
11.5.5 Perseon Medical Related Developments
11.6 Omron Corporation
11.6.1 Omron Corporation Corporation Information
11.6.2 Omron Corporation Description and Business Overview
11.6.3 Omron Corporation Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Omron Corporation Hyperthermia Treatment for Cancer Products Offered
11.6.5 Omron Corporation Related Developments
11.7 Sjn AG Yamamoto Vinita
11.7.1 Sjn AG Yamamoto Vinita Corporation Information
11.7.2 Sjn AG Yamamoto Vinita Description and Business Overview
11.7.3 Sjn AG Yamamoto Vinita Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Sjn AG Yamamoto Vinita Hyperthermia Treatment for Cancer Products Offered
11.7.5 Sjn AG Yamamoto Vinita Related Developments
11.1 Andromedic Sri
11.1.1 Andromedic Sri Corporation Information
11.1.2 Andromedic Sri Description and Business Overview
11.1.3 Andromedic Sri Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Andromedic Sri Hyperthermia Treatment for Cancer Products Offered
11.1.5 Andromedic Sri Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Hyperthermia Treatment for Cancer Market Estimates and Projections by Region
12.1.1 Global Hyperthermia Treatment for Cancer Sales Forecast by Regions 2021-2026
12.1.2 Global Hyperthermia Treatment for Cancer Revenue Forecast by Regions 2021-2026
12.2 North America Hyperthermia Treatment for Cancer Market Size Forecast (2021-2026)
12.2.1 North America: Hyperthermia Treatment for Cancer Sales Forecast (2021-2026)
12.2.2 North America: Hyperthermia Treatment for Cancer Revenue Forecast (2021-2026)
12.2.3 North America: Hyperthermia Treatment for Cancer Market Size Forecast by Country (2021-2026)
12.3 Europe Hyperthermia Treatment for Cancer Market Size Forecast (2021-2026)
12.3.1 Europe: Hyperthermia Treatment for Cancer Sales Forecast (2021-2026)
12.3.2 Europe: Hyperthermia Treatment for Cancer Revenue Forecast (2021-2026)
12.3.3 Europe: Hyperthermia Treatment for Cancer Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Hyperthermia Treatment for Cancer Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Hyperthermia Treatment for Cancer Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Hyperthermia Treatment for Cancer Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Hyperthermia Treatment for Cancer Market Size Forecast by Region (2021-2026)
12.5 Latin America Hyperthermia Treatment for Cancer Market Size Forecast (2021-2026)
12.5.1 Latin America: Hyperthermia Treatment for Cancer Sales Forecast (2021-2026)
12.5.2 Latin America: Hyperthermia Treatment for Cancer Revenue Forecast (2021-2026)
12.5.3 Latin America: Hyperthermia Treatment for Cancer Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Hyperthermia Treatment for Cancer Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Hyperthermia Treatment for Cancer Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Hyperthermia Treatment for Cancer Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Hyperthermia Treatment for Cancer Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Hyperthermia Treatment for Cancer Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hyperthermia Treatment for Cancer Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Hyperthermia Treatment for Cancer Market Segments
Table 2. Ranking of Global Top Hyperthermia Treatment for Cancer Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Hyperthermia Treatment for Cancer Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Microwave Hyperthermia Device
Table 5. Major Manufacturers of Ultrasound Hyperthermia Device
Table 6. Major Manufacturers of Infrared Therapy Device
Table 7. Major Manufacturers of Short-wave Therapy Device
Table 8. Global Hyperthermia Treatment for Cancer Market Size Growth Rate by Application 2020-2026 (K Units)
Table 9. Global Hyperthermia Treatment for Cancer Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 10. Global Hyperthermia Treatment for Cancer Sales by Regions 2015-2020 (K Units)
Table 11. Global Hyperthermia Treatment for Cancer Sales Market Share by Regions (2015-2020)
Table 12. Global Hyperthermia Treatment for Cancer Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Hyperthermia Treatment for Cancer Sales by Manufacturers (2015-2020) (K Units)
Table 14. Global Hyperthermia Treatment for Cancer Sales Share by Manufacturers (2015-2020)
Table 15. Global Hyperthermia Treatment for Cancer Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Hyperthermia Treatment for Cancer by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hyperthermia Treatment for Cancer as of 2019)
Table 17. Hyperthermia Treatment for Cancer Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Hyperthermia Treatment for Cancer Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Hyperthermia Treatment for Cancer Price (2015-2020) (USD/Unit)
Table 20. Hyperthermia Treatment for Cancer Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Hyperthermia Treatment for Cancer Product Type
Table 22. Date of International Manufacturers Enter into Hyperthermia Treatment for Cancer Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Hyperthermia Treatment for Cancer Sales by Type (2015-2020) (K Units)
Table 25. Global Hyperthermia Treatment for Cancer Sales Share by Type (2015-2020)
Table 26. Global Hyperthermia Treatment for Cancer Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Hyperthermia Treatment for Cancer Revenue Share by Type (2015-2020)
Table 28. Hyperthermia Treatment for Cancer Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 29. Global Hyperthermia Treatment for Cancer Sales by Application (2015-2020) (K Units)
Table 30. Global Hyperthermia Treatment for Cancer Sales Share by Application (2015-2020)
Table 31. North America Hyperthermia Treatment for Cancer Sales by Country (2015-2020) (K Units)
Table 32. North America Hyperthermia Treatment for Cancer Sales Market Share by Country (2015-2020)
Table 33. North America Hyperthermia Treatment for Cancer Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Hyperthermia Treatment for Cancer Revenue Market Share by Country (2015-2020)
Table 35. North America Hyperthermia Treatment for Cancer Sales by Type (2015-2020) (K Units)
Table 36. North America Hyperthermia Treatment for Cancer Sales Market Share by Type (2015-2020)
Table 37. North America Hyperthermia Treatment for Cancer Sales by Application (2015-2020) (K Units)
Table 38. North America Hyperthermia Treatment for Cancer Sales Market Share by Application (2015-2020)
Table 39. Europe Hyperthermia Treatment for Cancer Sales by Country (2015-2020) (K Units)
Table 40. Europe Hyperthermia Treatment for Cancer Sales Market Share by Country (2015-2020)
Table 41. Europe Hyperthermia Treatment for Cancer Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Hyperthermia Treatment for Cancer Revenue Market Share by Country (2015-2020)
Table 43. Europe Hyperthermia Treatment for Cancer Sales by Type (2015-2020) (K Units)
Table 44. Europe Hyperthermia Treatment for Cancer Sales Market Share by Type (2015-2020)
Table 45. Europe Hyperthermia Treatment for Cancer Sales by Application (2015-2020) (K Units)
Table 46. Europe Hyperthermia Treatment for Cancer Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Hyperthermia Treatment for Cancer Sales by Region (2015-2020) (K Units)
Table 48. Asia Pacific Hyperthermia Treatment for Cancer Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Hyperthermia Treatment for Cancer Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Hyperthermia Treatment for Cancer Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Hyperthermia Treatment for Cancer Sales by Type (2015-2020) (K Units)
Table 52. Asia Pacific Hyperthermia Treatment for Cancer Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Hyperthermia Treatment for Cancer Sales by Application (2015-2020) (K Units)
Table 54. Asia Pacific Hyperthermia Treatment for Cancer Sales Market Share by Application (2015-2020)
Table 55. Latin America Hyperthermia Treatment for Cancer Sales by Country (2015-2020) (K Units)
Table 56. Latin America Hyperthermia Treatment for Cancer Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Hyperthermia Treatment for Cancer Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Hyperthermia Treatment for Cancer Revenue Market Share by Country (2015-2020)
Table 59. Latin America Hyperthermia Treatment for Cancer Sales by Type (2015-2020) (K Units)
Table 60. Latin America Hyperthermia Treatment for Cancer Sales Market Share by Type (2015-2020)
Table 61. Latin America Hyperthermia Treatment for Cancer Sales by Application (2015-2020) (K Units)
Table 62. Latin America Hyperthermia Treatment for Cancer Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Hyperthermia Treatment for Cancer Sales by Country (2015-2020) (K Units)
Table 64. Middle East and Africa Hyperthermia Treatment for Cancer Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Hyperthermia Treatment for Cancer Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Hyperthermia Treatment for Cancer Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Hyperthermia Treatment for Cancer Sales by Type (2015-2020) (K Units)
Table 68. Middle East and Africa Hyperthermia Treatment for Cancer Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Hyperthermia Treatment for Cancer Sales by Application (2015-2020) (K Units)
Table 70. Middle East and Africa Hyperthermia Treatment for Cancer Sales Market Share by Application (2015-2020)
Table 71. Andromedic Sri Corporation Information
Table 72. Andromedic Sri Description and Major Businesses
Table 73. Andromedic Sri Hyperthermia Treatment for Cancer Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 74. Andromedic Sri Product
Table 75. Andromedic Sri Recent Development
Table 76. Celsius42 GmbH Corporation Information
Table 77. Celsius42 GmbH Description and Major Businesses
Table 78. Celsius42 GmbH Hyperthermia Treatment for Cancer Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. Celsius42 GmbH Product
Table 80. Celsius42 GmbH Recent Development
Table 81. Huahang Corporation Information
Table 82. Huahang Description and Major Businesses
Table 83. Huahang Hyperthermia Treatment for Cancer Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Huahang Product
Table 85. Huahang Recent Development
Table 86. Pyrexar Medical Corporation Information
Table 87. Pyrexar Medical Description and Major Businesses
Table 88. Pyrexar Medical Hyperthermia Treatment for Cancer Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Pyrexar Medical Product
Table 90. Pyrexar Medical Recent Development
Table 91. Perseon Medical Corporation Information
Table 92. Perseon Medical Description and Major Businesses
Table 93. Perseon Medical Hyperthermia Treatment for Cancer Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Perseon Medical Product
Table 95. Perseon Medical Recent Development
Table 96. Omron Corporation Corporation Information
Table 97. Omron Corporation Description and Major Businesses
Table 98. Omron Corporation Hyperthermia Treatment for Cancer Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. Omron Corporation Product
Table 100. Omron Corporation Recent Development
Table 101. Sjn AG Yamamoto Vinita Corporation Information
Table 102. Sjn AG Yamamoto Vinita Description and Major Businesses
Table 103. Sjn AG Yamamoto Vinita Hyperthermia Treatment for Cancer Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Sjn AG Yamamoto Vinita Product
Table 105. Sjn AG Yamamoto Vinita Recent Development
Table 106. Global Hyperthermia Treatment for Cancer Sales Forecast by Regions (2021-2026) (K Units)
Table 107. Global Hyperthermia Treatment for Cancer Sales Market Share Forecast by Regions (2021-2026)
Table 108. Global Hyperthermia Treatment for Cancer Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 109. Global Hyperthermia Treatment for Cancer Revenue Market Share Forecast by Regions (2021-2026)
Table 110. North America: Hyperthermia Treatment for Cancer Sales Forecast by Country (2021-2026) (K Units)
Table 111. North America: Hyperthermia Treatment for Cancer Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Europe: Hyperthermia Treatment for Cancer Sales Forecast by Country (2021-2026) (K Units)
Table 113. Europe: Hyperthermia Treatment for Cancer Revenue Forecast by Country (2021-2026) (US$ Million)
Table 114. Asia Pacific: Hyperthermia Treatment for Cancer Sales Forecast by Region (2021-2026) (K Units)
Table 115. Asia Pacific: Hyperthermia Treatment for Cancer Revenue Forecast by Region (2021-2026) (US$ Million)
Table 116. Latin America: Hyperthermia Treatment for Cancer Sales Forecast by Country (2021-2026) (K Units)
Table 117. Latin America: Hyperthermia Treatment for Cancer Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Middle East and Africa: Hyperthermia Treatment for Cancer Sales Forecast by Country (2021-2026) (K Units)
Table 119. Middle East and Africa: Hyperthermia Treatment for Cancer Revenue Forecast by Country (2021-2026) (US$ Million)
Table 120. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 121. Key Challenges
Table 122. Market Risks
Table 123. Main Points Interviewed from Key Hyperthermia Treatment for Cancer Players
Table 124. Hyperthermia Treatment for Cancer Customers List
Table 125. Hyperthermia Treatment for Cancer Distributors List
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Hyperthermia Treatment for Cancer Product Picture
Figure 2. Global Hyperthermia Treatment for Cancer Sales Market Share by Type in 2020 & 2026
Figure 3. Microwave Hyperthermia Device Product Picture
Figure 4. Ultrasound Hyperthermia Device Product Picture
Figure 5. Infrared Therapy Device Product Picture
Figure 6. Short-wave Therapy Device Product Picture
Figure 7. Global Hyperthermia Treatment for Cancer Sales Market Share by Application in 2020 & 2026
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Research Institutes
Figure 11. Hyperthermia Treatment for Cancer Report Years Considered
Figure 12. Global Hyperthermia Treatment for Cancer Market Size 2015-2026 (US$ Million)
Figure 13. Global Hyperthermia Treatment for Cancer Sales 2015-2026 (K Units)
Figure 14. Global Hyperthermia Treatment for Cancer Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Hyperthermia Treatment for Cancer Sales Market Share by Region (2015-2020)
Figure 16. Global Hyperthermia Treatment for Cancer Sales Market Share by Region in 2019
Figure 17. Global Hyperthermia Treatment for Cancer Revenue Market Share by Region (2015-2020)
Figure 18. Global Hyperthermia Treatment for Cancer Revenue Market Share by Region in 2019
Figure 19. Global Hyperthermia Treatment for Cancer Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Hyperthermia Treatment for Cancer Revenue in 2019
Figure 21. Hyperthermia Treatment for Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Hyperthermia Treatment for Cancer Sales Market Share by Type (2015-2020)
Figure 23. Global Hyperthermia Treatment for Cancer Sales Market Share by Type in 2019
Figure 24. Global Hyperthermia Treatment for Cancer Revenue Market Share by Type (2015-2020)
Figure 25. Global Hyperthermia Treatment for Cancer Revenue Market Share by Type in 2019
Figure 26. Global Hyperthermia Treatment for Cancer Market Share by Price Range (2015-2020)
Figure 27. Global Hyperthermia Treatment for Cancer Sales Market Share by Application (2015-2020)
Figure 28. Global Hyperthermia Treatment for Cancer Sales Market Share by Application in 2019
Figure 29. Global Hyperthermia Treatment for Cancer Revenue Market Share by Application (2015-2020)
Figure 30. Global Hyperthermia Treatment for Cancer Revenue Market Share by Application in 2019
Figure 31. North America Hyperthermia Treatment for Cancer Sales Growth Rate 2015-2020 (K Units)
Figure 32. North America Hyperthermia Treatment for Cancer Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Hyperthermia Treatment for Cancer Sales Market Share by Country in 2019
Figure 34. North America Hyperthermia Treatment for Cancer Revenue Market Share by Country in 2019
Figure 35. U.S. Hyperthermia Treatment for Cancer Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.S. Hyperthermia Treatment for Cancer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Hyperthermia Treatment for Cancer Sales Growth Rate (2015-2020) (K Units)
Figure 38. Canada Hyperthermia Treatment for Cancer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Hyperthermia Treatment for Cancer Market Share by Type in 2019
Figure 40. North America Hyperthermia Treatment for Cancer Market Share by Application in 2019
Figure 41. Europe Hyperthermia Treatment for Cancer Sales Growth Rate 2015-2020 (K Units)
Figure 42. Europe Hyperthermia Treatment for Cancer Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Hyperthermia Treatment for Cancer Sales Market Share by Country in 2019
Figure 44. Europe Hyperthermia Treatment for Cancer Revenue Market Share by Country in 2019
Figure 45. Germany Hyperthermia Treatment for Cancer Sales Growth Rate (2015-2020) (K Units)
Figure 46. Germany Hyperthermia Treatment for Cancer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Hyperthermia Treatment for Cancer Sales Growth Rate (2015-2020) (K Units)
Figure 48. France Hyperthermia Treatment for Cancer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Hyperthermia Treatment for Cancer Sales Growth Rate (2015-2020) (K Units)
Figure 50. U.K. Hyperthermia Treatment for Cancer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Hyperthermia Treatment for Cancer Sales Growth Rate (2015-2020) (K Units)
Figure 52. Italy Hyperthermia Treatment for Cancer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Hyperthermia Treatment for Cancer Sales Growth Rate (2015-2020) (K Units)
Figure 54. Russia Hyperthermia Treatment for Cancer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Hyperthermia Treatment for Cancer Market Share by Type in 2019
Figure 56. Europe Hyperthermia Treatment for Cancer Market Share by Application in 2019
Figure 57. Asia Pacific Hyperthermia Treatment for Cancer Sales Growth Rate 2015-2020 (K Units)
Figure 58. Asia Pacific Hyperthermia Treatment for Cancer Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Hyperthermia Treatment for Cancer Sales Market Share by Region in 2019
Figure 60. Asia Pacific Hyperthermia Treatment for Cancer Revenue Market Share by Region in 2019
Figure 61. China Hyperthermia Treatment for Cancer Sales Growth Rate (2015-2020) (K Units)
Figure 62. China Hyperthermia Treatment for Cancer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Hyperthermia Treatment for Cancer Sales Growth Rate (2015-2020) (K Units)
Figure 64. Japan Hyperthermia Treatment for Cancer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Hyperthermia Treatment for Cancer Sales Growth Rate (2015-2020) (K Units)
Figure 66. South Korea Hyperthermia Treatment for Cancer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Hyperthermia Treatment for Cancer Sales Growth Rate (2015-2020) (K Units)
Figure 68. India Hyperthermia Treatment for Cancer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Hyperthermia Treatment for Cancer Sales Growth Rate (2015-2020) (K Units)
Figure 70. Australia Hyperthermia Treatment for Cancer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Hyperthermia Treatment for Cancer Sales Growth Rate (2015-2020) (K Units)
Figure 72. Taiwan Hyperthermia Treatment for Cancer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Hyperthermia Treatment for Cancer Sales Growth Rate (2015-2020) (K Units)
Figure 74. Indonesia Hyperthermia Treatment for Cancer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Hyperthermia Treatment for Cancer Sales Growth Rate (2015-2020) (K Units)
Figure 76. Thailand Hyperthermia Treatment for Cancer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Hyperthermia Treatment for Cancer Sales Growth Rate (2015-2020) (K Units)
Figure 78. Malaysia Hyperthermia Treatment for Cancer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Hyperthermia Treatment for Cancer Sales Growth Rate (2015-2020) (K Units)
Figure 80. Philippines Hyperthermia Treatment for Cancer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Hyperthermia Treatment for Cancer Sales Growth Rate (2015-2020) (K Units)
Figure 82. Vietnam Hyperthermia Treatment for Cancer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Hyperthermia Treatment for Cancer Market Share by Type in 2019
Figure 84. Asia Pacific Hyperthermia Treatment for Cancer Market Share by Application in 2019
Figure 85. Latin America Hyperthermia Treatment for Cancer Sales Growth Rate 2015-2020 (K Units)
Figure 86. Latin America Hyperthermia Treatment for Cancer Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Hyperthermia Treatment for Cancer Sales Market Share by Country in 2019
Figure 88. Latin America Hyperthermia Treatment for Cancer Revenue Market Share by Country in 2019
Figure 89. Mexico Hyperthermia Treatment for Cancer Sales Growth Rate (2015-2020) (K Units)
Figure 90. Mexico Hyperthermia Treatment for Cancer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Hyperthermia Treatment for Cancer Sales Growth Rate (2015-2020) (K Units)
Figure 92. Brazil Hyperthermia Treatment for Cancer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Hyperthermia Treatment for Cancer Sales Growth Rate (2015-2020) (K Units)
Figure 94. Argentina Hyperthermia Treatment for Cancer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Hyperthermia Treatment for Cancer Market Share by Type in 2019
Figure 96. Latin America Hyperthermia Treatment for Cancer Market Share by Application in 2019
Figure 97. Middle East and Africa Hyperthermia Treatment for Cancer Sales Growth Rate 2015-2020 (K Units)
Figure 98. Middle East and Africa Hyperthermia Treatment for Cancer Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Hyperthermia Treatment for Cancer Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Hyperthermia Treatment for Cancer Revenue Market Share by Country in 2019
Figure 101. Turkey Hyperthermia Treatment for Cancer Sales Growth Rate (2015-2020) (K Units)
Figure 102. Turkey Hyperthermia Treatment for Cancer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Hyperthermia Treatment for Cancer Sales Growth Rate (2015-2020) (K Units)
Figure 104. Saudi Arabia Hyperthermia Treatment for Cancer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Hyperthermia Treatment for Cancer Sales Growth Rate (2015-2020) (K Units)
Figure 106. U.A.E Hyperthermia Treatment for Cancer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Hyperthermia Treatment for Cancer Market Share by Type in 2019
Figure 108. Middle East and Africa Hyperthermia Treatment for Cancer Market Share by Application in 2019
Figure 109. North America Hyperthermia Treatment for Cancer Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. North America Hyperthermia Treatment for Cancer Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Hyperthermia Treatment for Cancer Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Europe Hyperthermia Treatment for Cancer Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Hyperthermia Treatment for Cancer Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Asia Pacific Hyperthermia Treatment for Cancer Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Hyperthermia Treatment for Cancer Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Latin America Hyperthermia Treatment for Cancer Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Hyperthermia Treatment for Cancer Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Middle East and Africa Hyperthermia Treatment for Cancer Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
ハイパーサーミアシステムの世界市場（～2026年） Hyperthermia is a therapeutic method for the treatment of cancer cells and tumors. The therapy involves heating of tumor up to 42°C, along with the standard therapy named as, chemotherapy or radiation therapy. Hyperthermia systems are used for the treatment of tumors, resisting the follow on medical…- 左室補助装置（LVAD）治療の世界市場（～2026年） Left Ventricular Assist Device is used to treat heart failure, as the bridge to transplant or destination therapy. Market Analysis and Insights: Global Left Ventricular Assist Device Treatment Market The global Left Ventricular Assist Device Treatment market size is projected to reach US$ XX million…
- 子宮筋腫治療装置の世界市場（～2026年） Uterine fibroids are noncancerous growths of the uterus that often appear during childbearing years. Also called leiomyomas (lie-o-my-O-muhs) or myomas, uterine fibroids aren't associated with an increased risk of uterine cancer and almost never develop into cancer. Market Analysis and Insights: Glo…
- 転移性がん治療の世界市場（～2026年） Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast can…
- 転移性膵臓がん治療の世界市場（～2026年） Metastatic pancreatic cancer treatment, when cancer spreads outside of the pancreas, surgery may or may not be recommended. It’s more common for oncologists to recommend systemic treatments (which can circulate throughout the entire body and destroy cancerous cells in multiple locations) for metasta…